Cargando…

Integrative analysis of genomic and transcriptomic alterations of AGR2 and AGR3 in cancer

The AGR2 and AGR3 genes have been shown by numerous groups to be functionally associated with adenocarcinoma progression and metastasis. In this paper, we explore the data available in databases concerning genomic and transcriptomic features of these two genes: the NCBI dbSNP database was used to ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Fessart, Delphine, Villamor, Ines, Chevet, Eric, Delom, Frederic, Robert, Jacques
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277299/
https://www.ncbi.nlm.nih.gov/pubmed/35857928
http://dx.doi.org/10.1098/rsob.220068
_version_ 1784745926742507520
author Fessart, Delphine
Villamor, Ines
Chevet, Eric
Delom, Frederic
Robert, Jacques
author_facet Fessart, Delphine
Villamor, Ines
Chevet, Eric
Delom, Frederic
Robert, Jacques
author_sort Fessart, Delphine
collection PubMed
description The AGR2 and AGR3 genes have been shown by numerous groups to be functionally associated with adenocarcinoma progression and metastasis. In this paper, we explore the data available in databases concerning genomic and transcriptomic features of these two genes: the NCBI dbSNP database was used to explore the presence and roles of constitutional SNPs, and the NCI, Cancer Cell Line Encyclopedia (CCLE) and TCGA databases were used to explore somatic mutations and copy number variations (CNVs), as well as mRNA expression of these genes in human cancer cell lines and tumours. Relationships of AGR2/3 expression with whole-genome mRNA expression and cancer features (i.e. mutations and CNVs of oncogenes and tumour suppressor genes (TSG)) were established using the CCLE and TCGA databases. In addition, the CCLE data concerning CRISPR gene extinction screens (Achilles project) of these two genes and a panel of oncogenes and TSG were explored. We observed that no functional polymorphism or recurrent mutation could be detected in AGR2 or AGR3. The expression of these genes was positively correlated with the expression of epithelial genes and inversely correlated with that of mesenchymal genes. It was also significantly associated with several cancer features, such as TP53 or SMAD4 mutations, depending on the gene and the cancer type. In addition, the CRISPR screens revealed the absence of cell fitness modification upon gene extinction, in contrast with oncogenes (cell fitness decrease) and TSG (cell fitness increase). Overall, these explorations revealed that AGR2 and AGR3 proteins appear as common non-genetic evolutionary factors in the process of human tumorigenesis.
format Online
Article
Text
id pubmed-9277299
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The Royal Society
record_format MEDLINE/PubMed
spelling pubmed-92772992022-07-15 Integrative analysis of genomic and transcriptomic alterations of AGR2 and AGR3 in cancer Fessart, Delphine Villamor, Ines Chevet, Eric Delom, Frederic Robert, Jacques Open Biol Research The AGR2 and AGR3 genes have been shown by numerous groups to be functionally associated with adenocarcinoma progression and metastasis. In this paper, we explore the data available in databases concerning genomic and transcriptomic features of these two genes: the NCBI dbSNP database was used to explore the presence and roles of constitutional SNPs, and the NCI, Cancer Cell Line Encyclopedia (CCLE) and TCGA databases were used to explore somatic mutations and copy number variations (CNVs), as well as mRNA expression of these genes in human cancer cell lines and tumours. Relationships of AGR2/3 expression with whole-genome mRNA expression and cancer features (i.e. mutations and CNVs of oncogenes and tumour suppressor genes (TSG)) were established using the CCLE and TCGA databases. In addition, the CCLE data concerning CRISPR gene extinction screens (Achilles project) of these two genes and a panel of oncogenes and TSG were explored. We observed that no functional polymorphism or recurrent mutation could be detected in AGR2 or AGR3. The expression of these genes was positively correlated with the expression of epithelial genes and inversely correlated with that of mesenchymal genes. It was also significantly associated with several cancer features, such as TP53 or SMAD4 mutations, depending on the gene and the cancer type. In addition, the CRISPR screens revealed the absence of cell fitness modification upon gene extinction, in contrast with oncogenes (cell fitness decrease) and TSG (cell fitness increase). Overall, these explorations revealed that AGR2 and AGR3 proteins appear as common non-genetic evolutionary factors in the process of human tumorigenesis. The Royal Society 2022-07-13 /pmc/articles/PMC9277299/ /pubmed/35857928 http://dx.doi.org/10.1098/rsob.220068 Text en © 2022 The Authors. https://creativecommons.org/licenses/by/4.0/Published by the Royal Society under the terms of the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, provided the original author and source are credited.
spellingShingle Research
Fessart, Delphine
Villamor, Ines
Chevet, Eric
Delom, Frederic
Robert, Jacques
Integrative analysis of genomic and transcriptomic alterations of AGR2 and AGR3 in cancer
title Integrative analysis of genomic and transcriptomic alterations of AGR2 and AGR3 in cancer
title_full Integrative analysis of genomic and transcriptomic alterations of AGR2 and AGR3 in cancer
title_fullStr Integrative analysis of genomic and transcriptomic alterations of AGR2 and AGR3 in cancer
title_full_unstemmed Integrative analysis of genomic and transcriptomic alterations of AGR2 and AGR3 in cancer
title_short Integrative analysis of genomic and transcriptomic alterations of AGR2 and AGR3 in cancer
title_sort integrative analysis of genomic and transcriptomic alterations of agr2 and agr3 in cancer
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277299/
https://www.ncbi.nlm.nih.gov/pubmed/35857928
http://dx.doi.org/10.1098/rsob.220068
work_keys_str_mv AT fessartdelphine integrativeanalysisofgenomicandtranscriptomicalterationsofagr2andagr3incancer
AT villamorines integrativeanalysisofgenomicandtranscriptomicalterationsofagr2andagr3incancer
AT cheveteric integrativeanalysisofgenomicandtranscriptomicalterationsofagr2andagr3incancer
AT delomfrederic integrativeanalysisofgenomicandtranscriptomicalterationsofagr2andagr3incancer
AT robertjacques integrativeanalysisofgenomicandtranscriptomicalterationsofagr2andagr3incancer